VTU Technology brings protein expression to CPhI

Grambach, Austria: – Protein expression specialist VTU Technology will present its wide-ranging Pichia pastoris protein production toolbox when it makes its debut as an exhibitor at Europe’s largest pharmaceutical trade fair, CPhI Worldwide in Frankfurt in late October.

VTU’s stand at Booth 41G30 will form part of the Austrian Pavilion at Messe, Frankfurt.

VTU’s Head of Business Development Dr. Thomas Purkarthofer, will lead the team at CPhI Worldwide, where it will present latest advances and applications of its world-leading Pichia pastoris recombinant production platform for higher efficiency production of a wide range of recombinant protein candidates.

The team will also use the event´s partnering systems to reach out to new collaborators from different industries such as biopharmaceutical, food & feed, diagnostics, chemical and agro-industry.

“Our experience over recent years has confirmed for us how important it is to meet our existing and potential customers face to face,” said Dr. Purkarthofer.

VTU offers customized high-performance protein production strains and offer straightforward cultivation & purification process development and optimization services paired with seamless technology transfer. Preparation and characterization of microbial cell banks and development of high-value enzymes through enzyme engineering services complement VTU´s broad service portfolio.

VTU´s Pichia technology is being used to produce numerous commercial proteins in each case meeting the demands of different regulatory authorities. All components of VTU´s Pichia toolbox are animal-origin-free and thoroughly characterized and full documentation is readily available to support regulatory filings.

“With the advances we’ve made during the past years, we can showcase even more powerful Pichia pastoris applications, including enhancements to our glycoprotein production package by combining our proprietary Pichia pastoris production platform with RCT´s Pichia GlycoSwitch system enabling boosted production of tailored glycoproteins,” Dr. Purkarthofer said.

High productivity

“VTU Technology provides industrial protein production solutions ideally suited for efficient large scale manufacturing processes with exceptionally high yields leading to low cost-of-goods,” Dr. Purkarthofer noted.

“VTU Pichia not only enables high volumetric productivities but also simplifies downstream processing due to efficient product secretion and low levels of endogenous proteins in the culture supernatant,” he added.

About VTU Technology

VTU Technology, a leading contract research and development company, offers the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression / production enabling highest productivities delivering up to 25 g/L of secreted protein (record productivities of 35 g/L) within a few weeks development time.

VTU´s yield-enhancing Pichia pastoris expression platform is based on its proprietary AOX1 promoter libraries and set of expression enhancing helper factors, several platform strains with different genetic backgrounds, elaborated cloning and transformation protocols, a high-throughput screening and cultivation regime combined with excellent know-how in fermentation and downstream process development for maximization of product yield and overall process performance.

Headquartered in Grambach, near Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in chemistry, pharma and life science as well as in the energy industries.

More information: www.vtu-technology.com

About CPhI Worldwide 2017

CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors networking opportunities with potential international pharmaceutical partners and collaborators, as well as latest industry insights.

Now in its 28th year, CPhI 2017 is a three-day event opening October 24 at the Messe Frankfurt exhibition center. Last year’s event in Barcelona attracted some 42,000 delegates and more than 2,500 exhibitor companies from 155 countries worldwide.

CPhI Worldwide is held alongside four other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment, InnoPack pharmaceutical packaging and a new addition, the FDF show for Finish, Dosage and Formulations, bringing together every aspect of the finished dosage supply chain.

The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/.